Buprenorphine Tablet
Product Images NDC 58118-0501

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 58118-0501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine 01)

Chemical structure of Buprenorphine hydrochloride showing its molecular arrangement with labeled chemical groups and bonds.*

FDA Label Image

Image (Buprenorphine 02)

An instructional diagram showing the placement of a sublingual tablet under the tongue inside the mouth. The illustration depicts a hand placing a tablet beneath the tongue, emphasizing the sublingual route of administration.*

FDA Label Image

Buprenorphine Sl 2mg Tablet 30 Ct Blister Card (Buprenorphine 03)

Label for Buprenorphine HCL 2 mg sublingual tablets by Clinical Solutions Wholesale. The label displays the NDC 58118-0501-8 and a quantity of 30 tablets. It notes manufacture by Rhodes Pharmaceuticals in Coventry, RI, USA, with example lot and batch numbers, expiration year 2023, and repackaging address in Franklin, TN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.